JD Wetherspoon: why investors should head to the pub
Pub group JD Wetherspoon is a solid operator, and is due a bounce when the pandemic eases. Matthew Partridge picks the best way to play it.
It has been a dismal two years for pubs and restaurants. They were closed for long periods in 2020 and early 2021, and when they did reopen they faced various restrictions that were only gradually phased out. Then in the summer the “pingdemic” caused staff shortages before supply-chain difficulties dampened autumn trading.
To add insult to injury, the emergence of the new Omicron variant has led to calls for more restrictions, including masks in restaurants and possibly even closures and lockdowns, to be reintroduced.
Shareholders in pub chain JD Wetherspoon (LSE: JDW) have experienced a particularly bumpy ride. After doubling between March 2016 and March 2020, the share price plunged by 60% during the first wave of the crisis.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
It then staged a partial rebound as restrictions were lifted only to fall again during the autumn of 2020. The news of the vaccine sparked a second rally, propelling the stock back to levels near its pre-crisis high this spring. However, since then the shares have slipped by a third.
A sea of troubles
Wetherspoon, like its competitors, has been hit by a range of problems, including the slow pace at which older customers are returning to the pub and the impact of the homeworking revolution on sales of lunches.
Medium-term shifts in the labour market and rising food prices may also mean that margins will come under pressure. Still, all the indications are that people are starting to become more confident about returning to work and going out in general.
While there have been many false dawns over the past two years, what we know so far suggests that even in the worst-case scenario, the Omicron variant is more likely to delay, rather than derail, a complete return to normality, especially since new Covid-19 pills, which are set to become widely available early next year, are likely to slash hospitalisation and death rates.
In the longer run, Wetherspoon has several advantages. These include a strong brand name and a loyal following among its many fans. Its focus on beer and good-quality, affordable food underpinned sales growth of around 6%-7% a year between 2016 and 2019, while the company earned a solid 10% return on capital invested (a key gauge of profitability).
Even in the most conservative scenario, sales are expected to return to their pre-pandemic level by 2023, although profits may take a little longer to bounce back. Overall, this justifies the stock’s 2022 price/earnings (p/e) ratio of 15.
At the moment, the market is clearly moving against Wetherspoons, as shown by the fact that it is trading well below its 50-day and 200-day moving averages. I’d therefore wait until it has gone up by 10% from its current price of 857p to 945p before pulling the trigger. Once that happens, I’d go long at £2 per 1p, with a stop loss of 450p, which would give you a total downside of £990.
Sign up to Money Morning
Our team, led by award winning editors, is dedicated to delivering you the top news, analysis, and guides to help you manage your money, grow your investments and build wealth.
Matthew graduated from the University of Durham in 2004; he then gained an MSc, followed by a PhD at the London School of Economics.
He has previously written for a wide range of publications, including the Guardian and the Economist, and also helped to run a newsletter on terrorism. He has spent time at Lehman Brothers, Citigroup and the consultancy Lombard Street Research.
Matthew is the author of Superinvestors: Lessons from the greatest investors in history, published by Harriman House, which has been translated into several languages. His second book, Investing Explained: The Accessible Guide to Building an Investment Portfolio, is published by Kogan Page.
As senior writer, he writes the shares and politics & economics pages, as well as weekly Blowing It and Great Frauds in History columns He also writes a fortnightly reviews page and trading tips, as well as regular cover stories and multi-page investment focus features.
Follow Matthew on Twitter: @DrMatthewPartri
-
Cash hoarders take total UK savings to £2 trillion – why aren’t we investing?
Investment-shy Brits are hoarding huge amounts of cash in their savings accounts. We look at the case for saving versus investing.
By Katie Williams Published
-
The MoneyWeek Christmas Charity Appeal: who are we supporting and how to donate
This year MoneyWeek is supporting YoungMinds, tackling mental health for children and young people. Here’s why we are partnering with YoungMinds and how you can help.
By Kalpana Fitzpatrick Published
-
Should you invest in Trainline?
Ticket seller Trainline offers a useful service – and good prospects for investors
By Dr Matthew Partridge Published
-
Harworth doubles profit as revenue soars – should you buy?
Harworth, a specialist property developer, is well-aligned with government policies, with revenue expected to rise by over 50% this year, and a further 30% the year after.
By Dr Matthew Partridge Published
-
Bitcoin miner Riot Platforms bleeds money – what happens now?
Riot Platforms struggles to make a profit and looks absurdly overvalued. Are troubles brewing?
By Dr Matthew Partridge Published
-
M&S recovery has momentum: will it stick?
After years of decline, M&S seems to have turned a corner. But is this just a “dead cat bounce”?
By Dr Matthew Partridge Published
-
Is Alpha Group a good buy?
Alpha Group helps clients manage risks such as foreign exchange. After being promoted to the London Stock Exchange, does the stock still rally?
By Dr Matthew Partridge Published
-
Vistry sales improve – should you buy into the boom?
Housebuilder Vistry’s unusual business model has fuelled rapid sales growth amid a sluggish private sales market
By Dr Matthew Partridge Published
-
Ocado shares plunge after FTSE 100 demotion
Ocado remains unprofitable and overvalued. Is it time to let go of the online supermarket?
By Dr Matthew Partridge Published
-
Should you invest in Axos Bank?
Axos Financial is highly exposed to America’s commercial-property slump
By Dr Matthew Partridge Published